Literature DB >> 1137262

o,p'DDD therapy in invasive adrenocortical carcinoma.

D Becker, O P Schumacher.   

Abstract

Invasive adrenocortical carcinoma was diagnosed in two patients, 3 1/2 and 69 years of age, respectively. Therapy with o,p'DDD was begun immediately, and the patients have survived 4 1/12 and 7 9/12 years, respectively. The prolonged survival represents possible "cure" of inoperable disease following early initiation of therapy.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1137262     DOI： 10.7326/0003-4819-82-5-677

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  6 in total

1.  o,p'--DDD and adrenal carcinoma.

Authors:  P McKiernan; D A Doyle; G J Duffy; R P Towers; F A Duff; D K O'Donovan
Journal:  Ir J Med Sci       Date:  1978-12       Impact factor: 1.568

2.  Metastatic virilizing adrenocortical carcinoma: a rare case of cure with surgery and mitotane therapy.

Authors:  Sreelatha Chalasani; Hemender Singh Vats; Tarit K Banerjee; Alan K McKenzie
Journal:  Clin Med Res       Date:  2009-06

3.  Feminizing adrenocortical carcinoma in man.

Authors:  M Nishiki; K Amano; H Itoh; H Ezaki; Y Miyachi
Journal:  Jpn J Surg       Date:  1980-06

Review 4.  EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity.

Authors:  Rebecca V Steenaard; Marieke Rutjens; Madeleine H T Ettaieb; Max M van Noesel; Harm R Haak
Journal:  Discov Oncol       Date:  2022-04-18

5.  Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients.

Authors:  H R Haak; J Hermans; C J van de Velde; E G Lentjes; B M Goslings; G J Fleuren; H M Krans
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

6.  Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.

Authors:  Nada El Ghorayeb; Geneviève Rondeau; Mathieu Latour; Christian Cohade; Harold Olney; André Lacroix; Paul Perrotte; Alexis Sabourin; Tania L Mazzuco; Isabelle Bourdeau
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.